Skip to main content
Book cover

Advances in Mitochondrial Medicine

  • Book
  • © 2012

Overview

  • Discusses the role of mitochondrial dysfunction and the complex pathophysiological mechanisms associated with a growing number of illnesses
  • Follows a scientific approach to asses the complex and heterogenious relationships between mitochondria and calcium, apoptosis, oxidative phosphorylation, Reactive Oxygen Species and anabolic pathways
  • Discusses mitochondria as a valuable target for xenobiotics and its etiopathogenic role in neglected iatrogenic diseases, stimulating the use of existing knowledge for clinical applications, diagnosis and therapy

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 942)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. Physiology and Structure of Mitochondria

  2. Physiology and structure of Mitochondria

  3. Mitochondria and Disease

  4. Mitochondria and disease

  5. Mitochondria, Aging and Pharmacotoxicological Aspects

  6. Mitochondria and Aging

Keywords

About this book

Mitochondria are far more than the “powerhouse” of the cell as they have classically been described. In fact, mitochondria biological activities have progressively expanded to include not only various bioenergetic processes but also important biosynthetic pathways, calcium homeostasis and thermogenesis, cell death by apoptosis, several different signal transduction pathways mainly related to redox control of gene expression and so on. This functional and structural complexity may undergo important derangements so to justify the definition of ‘mitochondrial medicine’, which should include all the clinical consequences of congenital or acquired mitochondrial dysfunctions. There are actually a growing number of studies which assign a significant pathogenic role to damaged mitochondria in different diseases: ischemia/reperfusion injury, neurodegenerative diseases, cancer with its dramatic sequelae (i.e, metastasis), metabolic syndrome, hyperlipidemias, just to mention a few of the most important pathologies. In this context, a further aspect that should not be disregarded is the interaction of pharmacological agents with mitochondria, not only in regard of the toxicological aspects but, above all, of the potential therapeutic applications. In fact, it is interesting to note that, while the properties of different so-called “mitoxicants” are well-known, the subtle linkages between drugs and mitochondria is still in need of a real pharmacological and therapeutic control at the clinical level. This lack of consideration can often lead to an underestimation of unwanted toxic effects but also of desirable therapeutic activities. A reevaluation of the potential clinical role of mitochondria could give a new light on some yet obscure aspects of human pathophysiology.

Editors and Affiliations

  • School of Medicine, Institute of Biochemistry and Clinical B, Catholic University, Rome, Italy

    Roberto Scatena, Patrizia Bottoni, Bruno Giardina

Bibliographic Information

Publish with us